nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2D6—Parkinson's disease	0.852	1	CbGaD
Arformoterol—Isoprenaline—ADRBK1—Parkinson's disease	0.00541	0.496	CrCbGaD
Arformoterol—Dobutamine—COMT—Parkinson's disease	0.00338	0.31	CrCbGaD
Arformoterol—Formoterol—CYP2D6—Parkinson's disease	0.00122	0.112	CrCbGaD
Arformoterol—Labetalol—CYP2D6—Parkinson's disease	0.000891	0.0817	CrCbGaD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000124	0.000906	CbGpPWpGaD
Arformoterol—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000124	0.000905	CbGpPWpGaD
Arformoterol—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000124	0.0009	CbGpPWpGaD
Arformoterol—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000124	0.0009	CbGpPWpGaD
Arformoterol—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000123	0.000898	CbGpPWpGaD
Arformoterol—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000123	0.000897	CbGpPWpGaD
Arformoterol—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000123	0.000893	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	0.000123	0.000893	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	0.000123	0.000893	CbGpPWpGaD
Arformoterol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000123	0.000892	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000123	0.000892	CbGpPWpGaD
Arformoterol—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000122	0.000891	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	0.000122	0.000891	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GCH1—Parkinson's disease	0.000122	0.00089	CbGpPWpGaD
Arformoterol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000122	0.000888	CbGpPWpGaD
Arformoterol—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000122	0.000887	CbGpPWpGaD
Arformoterol—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000122	0.000885	CbGpPWpGaD
Arformoterol—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000121	0.00088	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.00012	0.000873	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.00012	0.000873	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.00012	0.000871	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	0.000114	0.000828	CbGpPWpGaD
Arformoterol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000114	0.000828	CbGpPWpGaD
Arformoterol—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000113	0.00082	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000112	0.000816	CbGpPWpGaD
Arformoterol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000112	0.000816	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.000111	0.00081	CbGpPWpGaD
Arformoterol—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000111	0.000809	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	0.000111	0.000806	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00011	0.000799	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—FBP1—Parkinson's disease	0.000109	0.000793	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—DBH—Parkinson's disease	0.000109	0.000793	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GBA—Parkinson's disease	0.000109	0.000793	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.000108	0.000789	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000107	0.000775	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000104	0.000758	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	9.8e-05	0.000714	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	9.69e-05	0.000705	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	9.67e-05	0.000704	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	9.59e-05	0.000698	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	9.48e-05	0.00069	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	9.46e-05	0.000689	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	9.31e-05	0.000677	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	9.29e-05	0.000676	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	9.24e-05	0.000673	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	9.1e-05	0.000662	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	9.09e-05	0.000662	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	9.04e-05	0.000658	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	8.93e-05	0.00065	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	8.9e-05	0.000648	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ND3—Parkinson's disease	8.76e-05	0.000638	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MCCC1—Parkinson's disease	8.76e-05	0.000638	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	8.73e-05	0.000635	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	8.64e-05	0.000629	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	8.49e-05	0.000618	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	8.46e-05	0.000615	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	8.39e-05	0.000611	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	8.34e-05	0.000607	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	8.26e-05	0.000602	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—OMD—Parkinson's disease	8.24e-05	0.0006	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—TALDO1—Parkinson's disease	8.24e-05	0.0006	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	8.21e-05	0.000598	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	8.15e-05	0.000594	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	8.11e-05	0.00059	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	8.08e-05	0.000588	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.07e-05	0.000587	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ND3—Parkinson's disease	8.06e-05	0.000587	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	8.06e-05	0.000587	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—DDC—Parkinson's disease	8e-05	0.000582	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MCCC1—Parkinson's disease	7.99e-05	0.000582	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ND3—Parkinson's disease	7.99e-05	0.000582	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	7.93e-05	0.000577	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	7.9e-05	0.000575	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	7.9e-05	0.000575	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.9e-05	0.000575	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	7.85e-05	0.000571	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	7.82e-05	0.000569	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	7.82e-05	0.000569	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	7.81e-05	0.000569	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	7.73e-05	0.000563	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	7.73e-05	0.000563	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	7.68e-05	0.000559	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	7.65e-05	0.000557	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	7.65e-05	0.000557	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.58e-05	0.000552	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—OMD—Parkinson's disease	7.58e-05	0.000552	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GSTA4—Parkinson's disease	7.55e-05	0.00055	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—TALDO1—Parkinson's disease	7.51e-05	0.000547	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—OMD—Parkinson's disease	7.51e-05	0.000547	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GCH1—Parkinson's disease	7.45e-05	0.000542	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	7.33e-05	0.000534	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	7.23e-05	0.000526	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	7.19e-05	0.000523	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	7.17e-05	0.000522	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	7.12e-05	0.000518	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	7.1e-05	0.000517	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	7.1e-05	0.000517	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	7.07e-05	0.000515	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	6.94e-05	0.000505	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	6.94e-05	0.000505	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.85e-05	0.000499	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PLA2G6—Parkinson's disease	6.8e-05	0.000495	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	6.8e-05	0.000495	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GCH1—Parkinson's disease	6.8e-05	0.000495	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MAOB—Parkinson's disease	6.73e-05	0.00049	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.72e-05	0.000489	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	6.72e-05	0.000489	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	6.65e-05	0.000484	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—DBH—Parkinson's disease	6.64e-05	0.000483	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—FBP1—Parkinson's disease	6.64e-05	0.000483	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GBA—Parkinson's disease	6.64e-05	0.000483	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	6.57e-05	0.000478	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	6.26e-05	0.000456	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.13e-05	0.000446	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	6.12e-05	0.000446	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GBA—Parkinson's disease	6.11e-05	0.000445	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—DBH—Parkinson's disease	6.11e-05	0.000445	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—FBP1—Parkinson's disease	6.11e-05	0.000445	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—DBH—Parkinson's disease	6.06e-05	0.000441	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—FBP1—Parkinson's disease	6.06e-05	0.000441	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GBA—Parkinson's disease	6.06e-05	0.000441	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	5.89e-05	0.000429	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	5.76e-05	0.00042	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	5.71e-05	0.000416	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	5.68e-05	0.000414	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	5.59e-05	0.000407	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	5.56e-05	0.000405	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	5.48e-05	0.000399	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	5.36e-05	0.00039	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	5.27e-05	0.000384	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	5.16e-05	0.000375	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CYP2D6—Parkinson's disease	5e-05	0.000364	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	4.98e-05	0.000363	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	4.97e-05	0.000362	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	4.96e-05	0.000361	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CTGF—Parkinson's disease	4.91e-05	0.000357	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	4.88e-05	0.000355	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—DDC—Parkinson's disease	4.88e-05	0.000355	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	4.88e-05	0.000355	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	4.86e-05	0.000354	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	4.85e-05	0.000353	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	4.79e-05	0.000348	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	4.78e-05	0.000348	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	4.68e-05	0.000341	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	4.64e-05	0.000338	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTA4—Parkinson's disease	4.6e-05	0.000335	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CYP2E1—Parkinson's disease	4.58e-05	0.000333	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.55e-05	0.000331	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	4.54e-05	0.00033	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—NQO1—Parkinson's disease	4.52e-05	0.000329	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—DDC—Parkinson's disease	4.48e-05	0.000326	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—TH—Parkinson's disease	4.46e-05	0.000325	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—DDC—Parkinson's disease	4.45e-05	0.000324	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	4.33e-05	0.000315	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CYCS—Parkinson's disease	4.28e-05	0.000312	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	4.24e-05	0.000308	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.23e-05	0.000308	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTA4—Parkinson's disease	4.2e-05	0.000306	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	4.19e-05	0.000305	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	4.19e-05	0.000305	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	4.15e-05	0.000302	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.14e-05	0.000302	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MAOB—Parkinson's disease	4.1e-05	0.000299	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	4.1e-05	0.000299	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	4.1e-05	0.000299	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.91e-05	0.000284	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.81e-05	0.000278	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—COMT—Parkinson's disease	3.79e-05	0.000276	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	3.78e-05	0.000275	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.77e-05	0.000275	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GSTP1—Parkinson's disease	3.77e-05	0.000275	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MAOA—Parkinson's disease	3.76e-05	0.000274	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MAOB—Parkinson's disease	3.74e-05	0.000272	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—HMOX1—Parkinson's disease	3.72e-05	0.000271	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—ABCB1—Parkinson's disease	3.57e-05	0.00026	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.56e-05	0.000259	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	3.51e-05	0.000256	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GSTM1—Parkinson's disease	3.47e-05	0.000252	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	3.44e-05	0.00025	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	3.4e-05	0.000247	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	3.36e-05	0.000244	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	3.32e-05	0.000242	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GPX1—Parkinson's disease	3.32e-05	0.000242	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	3.28e-05	0.000239	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	3.09e-05	0.000225	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MTHFR—Parkinson's disease	3.06e-05	0.000223	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	3.05e-05	0.000222	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	3.02e-05	0.00022	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CTGF—Parkinson's disease	2.99e-05	0.000218	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	2.94e-05	0.000214	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	2.87e-05	0.000209	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—APOE—Parkinson's disease	2.85e-05	0.000208	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.79e-05	0.000203	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	2.78e-05	0.000202	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.76e-05	0.000201	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.75e-05	0.0002	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	2.73e-05	0.000199	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CTGF—Parkinson's disease	2.73e-05	0.000199	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—TH—Parkinson's disease	2.72e-05	0.000198	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	2.67e-05	0.000194	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CYCS—Parkinson's disease	2.61e-05	0.00019	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.57e-05	0.000187	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.54e-05	0.000185	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.54e-05	0.000185	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.51e-05	0.000183	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—TH—Parkinson's disease	2.5e-05	0.000182	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—TH—Parkinson's disease	2.48e-05	0.00018	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—INS—Parkinson's disease	2.44e-05	0.000177	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.4e-05	0.000175	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.38e-05	0.000173	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—INS—Parkinson's disease	2.33e-05	0.00017	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—COMT—Parkinson's disease	2.31e-05	0.000168	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTP1—Parkinson's disease	2.3e-05	0.000167	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MAOA—Parkinson's disease	2.3e-05	0.000167	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—INS—Parkinson's disease	2.28e-05	0.000166	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—HMOX1—Parkinson's disease	2.27e-05	0.000165	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ABCB1—Parkinson's disease	2.18e-05	0.000158	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—COMT—Parkinson's disease	2.13e-05	0.000155	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.12e-05	0.000154	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GSTM1—Parkinson's disease	2.11e-05	0.000154	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.11e-05	0.000154	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—COMT—Parkinson's disease	2.11e-05	0.000153	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTP1—Parkinson's disease	2.1e-05	0.000153	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MAOA—Parkinson's disease	2.09e-05	0.000152	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.09e-05	0.000152	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—HMOX1—Parkinson's disease	2.07e-05	0.000151	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GPX1—Parkinson's disease	2.02e-05	0.000147	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2e-05	0.000146	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.99e-05	0.000145	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.94e-05	0.000142	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.93e-05	0.00014	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.87e-05	0.000136	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.86e-05	0.000136	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.85e-05	0.000134	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOE—Parkinson's disease	1.74e-05	0.000127	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.74e-05	0.000126	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.73e-05	0.000126	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.72e-05	0.000125	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.7e-05	0.000124	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	1.7e-05	0.000124	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	1.69e-05	0.000123	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.6e-05	0.000116	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.6e-05	0.000116	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOE—Parkinson's disease	1.59e-05	0.000115	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	1.56e-05	0.000114	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—INS—Parkinson's disease	1.49e-05	0.000108	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—INS—Parkinson's disease	1.37e-05	9.95e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—INS—Parkinson's disease	1.35e-05	9.86e-05	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	1.02e-05	7.42e-05	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	9.97e-06	7.26e-05	CbGpPWpGaD
